Michael Sinclair, Director, 10% Owner at OPIANT PHARMACEUTICALS, INC. (OPNT), sold 234,876 shares at $16.50 ($3.6M) on 2021-08-23, disclosed to the SEC on 2021-08-25.
Open-market sale of $3.6M OPNT by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.50 | 65,124 | $1.1M | 29.5% |
| 2 | $15.71 | 34,607 | $544K | 14.9% |
| 3 | $15.71 | 34,607 | $544K | 14.9% |
| 4 | $14.69 | 50,269 | $738K | 20.3% |
| 5 | $14.69 | 50,269 | $738K | 20.3% |
| Total | $15.49 avg | 234,876 |
| $3.6M |
| 100% |
| Filing → |
| OPNT | SELL | 2022-06-08 | $209K | — | Filing → |
| OPNT | SELL | 2022-06-06 | $549K | — | Filing → |
| OPNT | SELL | 2019-09-13 | $751K | — | Filing → |